Organogenesis Holdings Inc.
ORGO
$2.56
-$0.03-0.97%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 43.70M | 21.57M | -9.39M | -18.84M | 7.67M |
| Total Depreciation and Amortization | 4.86M | 4.87M | 4.58M | 4.29M | 4.45M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 34.52M | 6.52M | 10.06M | 15.34M | 5.59M |
| Change in Net Operating Assets | -43.67M | -29.88M | -38.12M | -20.71M | -6.78M |
| Cash from Operations | 39.42M | 3.08M | -32.87M | -19.94M | 10.94M |
| Capital Expenditure | -4.65M | -2.24M | -3.64M | -3.63M | -3.36M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -4.65M | -2.24M | -3.64M | -3.63M | -3.36M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -302.00K | -296.00K | -288.00K | -285.00K | -62.62M |
| Issuance of Common Stock | 2.00K | 130.00K | 0.00 | 25.00K | 1.06M |
| Repurchase of Common Stock | -87.00K | -2.00K | 0.00 | -1.80M | -25.48M |
| Issuance of Preferred Stock | -- | -- | -- | -- | 120.69M |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -4.42M | -10.04M | -- | -- | -- |
| Cash from Financing | -4.81M | -10.21M | -288.00K | -2.06M | 33.65M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 29.96M | -9.36M | -36.80M | -25.62M | 41.23M |